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TO THE EDITOR
Human skin is in permanent contact
with several potentially pathogenic
microorganisms. As the first site of
bacterial contact, keratinocytes have a
critical role in initiating a host defense
to invading microorganisms. To initiate
a rapid and effective defense response,
keratinocytes express specialized
receptors mediating innate recognition
of microorganisms. Such receptors,
termed pattern recognition receptors,
are ancient molecules of the innate
immune system and can be found in
plants, invertebrates, and vertebrates.
The most extensively studied pattern
recognition receptors are the Toll-like
receptors (TLRs), which comprise
evolutionarily conserved transmem-
brane proteins that recognize con-
served bacterial components such as
lipopolysaccharide, flagellin, lipopro-
teins, lipoteichoic acid, and unmethyl-
ated CpGDNA (Akira et al., 2006).
More recently, a previously unre-
ported class of intracellular nucleotide-
binding oligomerization domain
(NOD)-like receptors (NLRs) has been
discovered. Whereas TLRs sense bac-
terial products at the outer cell surface
or in endosomes, NLRs mediate the
cytoplasmic recognition of bacterial
products. The two best-studied mem-
bers of the NLR family, nucleotide-
binding oligomerization domain con-
taining 1 and 2 (NOD1 and NOD2) are
composed of an N-terminal caspase
recruitment domain, a centrally located
NOD and multiple C-terminal located
leucine-rich repeats (Franchi et al.,
2008). The leucine-rich repeat region
of NOD1 and NOD2 has been impli-
cated in the recognition of intracellular
pathogen components similar to the
homologous leucine-rich repeats of
plant disease resistance proteins (Dangl
and Jones, 2001) and TLRs (Underhill
and Ozinsky, 2002). NOD1 and NOD2
sense bacterial molecules produced
during the synthesis and/or degradation
of peptidoglycan. In particular, NOD1
mediates the sensing of peptidoglycan
fragments containing the amino-acid
meso-diaminopimelic acid that are
produced by most Gram-negative and
specific Gram-positive bacteria such as
Listeria monocytogenes (Chamaillard
et al., 2003; Girardin et al., 2003a). In
contrast, NOD2 mediates the sensing of
peptidoglycan-related molecules con-
taining muramyl dipeptide that are
produced by both Gram-negative and
Gram-positive bacteria (Girardin et al.,
2003b). The expression of NOD1 and
NOD2 was first detected in antigen-
presenting cells such as monocytes/
macrophages, but more recent studies
have also revealed the presence of
NOD1 and NOD2 in Paneth cells of
the small intestine as well as in other
epithelial cells (Ogura et al., 2001,
2003; Gutierrez et al., 2002; Lala
et al., 2003; Rosenstiel et al., 2003).
Recently, we reported the functional
expression of NOD2 in human kerati-
nocytes (Voss et al., 2006), but the
functional expression of NOD1 in
keratinocytes has not yet been studied.
To assess a possible function of
NOD1 in human keratinocytes, we first
analyzed whether NOD1 is expressed
in primary human adult keratinocytes (a
generous gift of Dr Stefan Stoll, Uni-
versity of Michigan). Real-time PCR
revealed gene expression of NOD1 in
human primary keratinocytes, and
NOD1 gene expression was slightly
upregulated by treatment of the cells
with IFN-g (Figure 1a). This is in
concordance with previous studies
describing an IFN-g-mediated upregu-
lation of NOD1 in intestinal epithelial
cells (Hisamatsu et al., 2003).
To explore the functional expression
of NOD1 in human keratinocytes, we
used primary keratinocytes as well as
human telomerase reverse transcriptase
(hTERT) keratinocytes. The hTERT kera-
tinocytes (provided by JP Rheinwald,
Boston) were derived from primary
keratinocytes immortalized by transfec-
tion to express the telomerase catalytic
subunit, hTERT, and retain normal
growth and differentiation characteris-
tics (Dickson et al., 2000). First, we
stimulated the keratinocytes with N-
myristoyl (C-14)-g-D-glutamyl-meso-dia-
minopimelic acid (KF1B), a known
NOD1 activator (Masumoto et al.,
2006). The use of chemically synthe-
sized KF1B avoids the risk of contam-
ination by other bacterial products. As it
is known that NOD1 activation induces
activation of the transcription factor
NF-kB, a NF-kB luciferase gene reporter
assay was used to analyze NF-kB
activation in the keratinocytes. For this
purpose hTERT keratinocytes as well as
human primary keratinocytes were
transfected for 24 h with an NF-kB firefly
luciferase reporter plasmid and an inter-
nal control renilla luciferase expression
plasmid as recently described (Voss
et al., 2006). Subsequently, cells were
stimulated for 20 h with the NOD1
activator KF1B, and NF-kB activation
was determined by measuring luciferase
activity using the Dual Luciferase assay
system (Promega, Madison, WI). As a
result we detected the activation of
NF-kB in primary and hTERT keratino-
cytes on treatment of the cells with
the NOD1 agonist KF1B, indicating
& 2009 The Society for Investigative Dermatology www.jidonline.org 1299
LETTERS TO THE EDITOR
Abbreviations: hTERT, human telomerase reverse transcriptase; KF1B, N-myristoyl (C-14)-g-D-glutamyl-
meso-diaminopimelic acid; NOD, nucleotide-binding oligomerization domain; shRNA, short-hairpin
RNA; TLR, Toll-like receptor
the functional expression of NOD1 in
human keratinocytes (Figure 1b, c).
To assess a functional role for NOD1
signaling in chemokine secretion, we
analyzed the secretion of CXCL8 (IL-8)
in KF1B-stimulated keratinocytes. Treat-
ment of primary as well as hTERT
keratinocytes with KF1B induced CXCL8
protein secretion (Figure 1d, e). To verify
that the KF1B-induced CXCL8 release
is mediated by NOD1, an RNA
interference approach was used to
selectively inhibit the expression of
NOD1 in keratinocytes. For this purpose
we generated hTERT keratinocytes sta-
bly expressing NOD1 short-hairpin RNA
(shRNA). For the shRNA knockdown of
NOD1 in hTERT keratinocytes, pGIPZ
lentiviral plasmids expressing micro-
RNA-adapted shRNA specific for
NOD1 and a nonsilencing control were
used (Open Biosystems, Huntsville, AL).
Lentiviruses expressing these shRNA
constructs were generated in human
embryonic kidney cells (HEK 293) by
transfecting these vectors together with
the package plasmids (psPAX2 and
pMD2.G; Open Biosystems) in a 1:1:1
ratio. Supernatants were collected after
24 h, filtered (0.45mM), diluted 1:1 with
Epilife medium (Cascade Biologics, Port-
land, OR) and used to infect hTERT
keratinocytes (70–80% confluence) in
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Figure 1. Expression and activation of NOD1 in human keratinocytes. (a) Primary human keratinocytes were stimulated for 20 h with the indicated
cytokines (40 ng ml1) and gene expression of NOD1 was analyzed using real-time PCR. The relative NOD1 expression is given as a ratio between NOD1 gene
expression and expression of the housekeeping gene GAPDH. PCR-negative controls revealed no products (not depicted). (b, c) hTERT keratinocytes (b)
as well as human primary keratinocytes (c) were stimulated for 20 h with the NOD1 activator KF1B (20 mg ml1) and subsequently analyzed for NF-kB
activation by measuring luciferase activity. (d, e) hTERT keratinocytes (d) as well as human primary keratinocytes (e) were stimulated for 20 h with the NOD1
activator KF1B (20 mg ml1) and CXCL8 secretion was determined using a CXCL8 ELISA (R&D Systems, Minneapolis, MN). Data shown are means±s.d. of
triplicate samples of one experiment representative of at least two independent experiments.
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the presence of 6mg ml1 polybrene for
48 h. Keratinocytes stably expressing the
shRNAs were selected by incubation
with puromycin (10mg ml1) for 3 days.
Selection efficiency was controlled by
monitoring the green fluorescence ex-
pression associated with the co-expres-
sion of the green fluorescent protein
encoded by the plasmids. The expres-
sion of the NOD1 shRNA in the hTERT
keratinocytes resulted in a distinct
decrease (B60%) of NOD1 gene
expression as revealed by real-time
PCR (Figure 2a). Treatment of these cells
with KF1B revealed reduced induction
of CXCL8 protein secretion as compared
to the control cells expressing a
nonsilencing shRNA (Figure 2b). These
data confirm that the KF1B-mediated
CXCL8 induction in keratinocytes
requires functional NOD1.
To obtain additional insight into the
biological role of NOD1 in keratinocytes,
we infected the NOD1 and control
shRNA-expressing keratinocytes with
living Pseudomonas aeruginosa, a
Gram-negative bacterium known to be
capable of activating NOD1 (Travassos
et al., 2005). To this end, NOD1 and
control shRNA-expressing keratinocytes
were incubated for 1 h with the P.
aeruginosa PAK strain (a generous gift
from Dr Reuben Ramphal, University of
Florida; bacteria/cell ratio B50:1, cen-
trifugation at 700g for 5 min to synchro-
nize infection). Subsequently, cells were
washed twice with phosphate-buffered
saline and the remaining extracellular
bacteria were killed by incubation of the
cells for 3 h in medium containing
300mg ml1 gentamycin. As a result,
infection with P. aeruginosa induced
CXCL8 protein release in keratinocytes
expressing the nonsilencing control
shRNA (Figure 2c). In contrast, NOD1
shRNA-expressing keratinocytes showed
a significant decreased CXCL8 protein
release on infection with P. aeruginosa.
These data confirm the functional rele-
vance of NOD1 in keratinocytes and
indicate that NOD1 is involved in the
detection of pathogenic bacteria in ker-
atinocytes. As keratinocytes express
NOD2 (Voss et al., 2006) as well as
TLRs (Baker et al., 2003; Pivarcsi et al.,
2003), it is likely that the remaining
P. aeruginosa-mediated induction of
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Figure 2. NOD1 mediates P. aeruginosa-induced CXCL8 secretion in human keratinocytes. (a) The knockdown efficiency of hTERT keratinocytes expressing
NOD1 shRNA was assessed by analyzing NOD1 gene expression using real-time PCR. (b) To confirm the functional knockdown of the NOD1 shRNA expressing
keratinocytes, we stimulated these cells and the keratinocytes expressing a control shRNA with the NOD1 activator KF1B (20 mg ml1) for 20 h. CXCL8 secretion
was determined using a CXCL8 ELISA and data are presented as fold induction of CXCL8 release compared to nonstimulated cells. Data represent the
means±s.d. from four independent experiments, each performed in triplicates. KF1B-induced secretion of CXCL8 was significantly decreased in NOD1 shRNA
expressing keratinocytes compared with the control shRNA expressing keratinocytes (Po0.01, Student’s t-test). (c) NOD1 and control shRNA expressing
keratinocytes were infected with the P. aeruginosa PAK strain and CXCL8 secretion was determined using a CXCL8 ELISA. Data are presented as fold induction
of CXCL8 release compared to nonstimulated cells and represent the means±s.d. from six independent experiments, each performed in triplicates.
P. aeruginosa-induced secretion of CXCL8 was significantly decreased in NOD1 shRNA expressing keratinocytes compared with the control shRNA
expressing keratinocytes (Po0.01, Student’s t-test).
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CXCL8 in the NOD1 shRNA-expressing
cells is mediated by such receptors.
In summary, to our knowledge this is
the first report demonstrating that the
intracellular receptor NOD1 is func-
tional expressed in human keratino-
cytes, suggesting that NOD1 may be
involved in cutaneous innate immunity.
Further studies are needed to under-
stand the contribution of intracellular
innate immune receptors to cutaneous
host defense.
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TO THE EDITOR
Mutations in the gene encoding filag-
grin (FLG) were identified as the under-
lying cause of ichthyosis vulgaris (IV;
OMIM #146700) and also shown to
predispose to atopic dermatitis (AD;
Palmer et al., 2006; Smith et al., 2006).
Although FLG is considerably difficult
to analyze because of its large size
(412 kb) and highly repetitive nature,
PCR strategy that permits routine and
comprehensive sequencing of the entire
FLG has been developed recently
(Sandilands et al., 2007).
Using this methodology, we have
identified four prevalent FLG mutations
in Japanese patients with IV (Nomura
et al., 2008). We also demonstrated that
FLG mutations were significantly asso-
ciated with AD and the frequency of
these FLG mutations observed in our
Japanese AD cohort was about 20%.
However, the frequency in our cohortAbbreviations: AD, atopic dermatitis; FLG, filaggrin; IV, ichthyosis vulgaris
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